ClinicalTrials.Veeva

Menu

Body Mass Index and Audiology Function

A

Assiut University

Status

Unknown

Conditions

Hearing Loss

Treatments

Device: pure tone audiometry

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Obesity may directly or indirectly lead to hearing loss

Full description

Obesity is measured by Body Mass Index.it is calculated by dividing a person's weight in kilograms by the square of height in meters. For children and adolescent. Overweight is defined as Body Mass Index is <85th percentile <95th percentile but obesity is defined as body mass index at or above the 95th percentile for children and teens of the same age and sex the increasing in body mass index mass may affect auditory function Directly as adipose tissue secretes hormones and cytokines, proinflammatory cytokines lead to release of obesity-induced inflammation which may directly contribute to end-organ damage Also, Adiponectin, which is thought to have anti-inflammatory and antiatherogenic effects, and associated with favorable lipoprotein profile, independent of BMI and insulin resistance, low plasma concentrations of adiponectin have been associated with obesity in children. In adults, low level of adiponectin has been associated with elevated high-frequency thresholds.

Indirectly, by obesity comorbidities including Hypertension, Type 2 diabetes mellitus, Dyslipidemia , Metabolic Syndrome and Cardiovascular Diseases

Enrollment

50 estimated patients

Sex

All

Ages

10 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

It will include 50 subjects whose:

  • Age ranges from 10 to 40 years old.
  • Body Mass Index more than the 85th percentile.
  • male and female will be included

Exclusion criteria

  • External or middle ear disease that causes conductive hearing loss such as otitis media, otomycosis, perforated drum, tumors, dislocation of the ossicles.
  • High environmental noise exposure which causes acoustic trauma such as exploration, fire shots and noise in industries.
  • ototoxic drug intake such as Aspirin, Aminoglycosides, Erythromycin, Vancomycin Streptomycin, Kanamycin, Neomycin, Gentamycin, Tobramycin, Lasix, Cisplatin, Nitrogen Mustard, and Vincristine, and Quinine.
  • Major neurological or psychiatric diseases brain tumor, vestibular Schwannoma, stroke, acoustic neuroma, encephalitis, meningitis, and depression.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

group 1
Experimental group
Treatment:
Device: pure tone audiometry
group 2
Active Comparator group
Treatment:
Device: pure tone audiometry

Trial contacts and locations

0

Loading...

Central trial contact

amira Mohammad Abdel Moneim, Lecturer; mohammed salama bakr, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems